» Articles » PMID: 10793146

Activation of Cdc42, Rac, PAK, and Rho-kinase in Response to Hepatocyte Growth Factor Differentially Regulates Epithelial Cell Colony Spreading and Dissociation

Overview
Journal Mol Biol Cell
Date 2000 May 4
PMID 10793146
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocyte growth factor (HGF), the ligand for the Met receptor tyrosine kinase, is a potent modulator of epithelial-mesenchymal transition and dispersal of epithelial cells, processes that play crucial roles in tumor development, invasion, and metastasis. Little is known about the Met-dependent proximal signals that regulate these events. We show that HGF stimulation of epithelial cells leads to activation of the Rho GTPases, Cdc42 and Rac, concomitant with the formation of filopodia and lamellipodia. Notably, HGF-dependent activation of Rac but not Cdc42 is dependent on phosphatidylinositol 3-kinase. Moreover, HGF-induced lamellipodia formation and cell spreading require phosphatidylinositol 3-kinase and are inhibited by dominant negative Cdc42 or Rac. HGF induces activation of the Cdc42/Rac-regulated p21-activated kinase (PAK) and c-Jun N-terminal kinase, and translocation of Rac, PAK, and Rho-dependent Rho-kinase to membrane ruffles. Use of dominant negative and activated mutants reveals an essential role for PAK but not Rho-kinase in HGF-induced epithelial cell spreading, whereas Rho-kinase activity is required for the formation of focal adhesions and stress fibers in response to HGF. We conclude that PAK and Rho-kinase play opposing roles in epithelial-mesenchymal transition induced by HGF, and provide new insight regarding the role of Cdc42 in these events.

Citing Articles

The Important Role of p21-Activated Kinases in Pancreatic Exocrine Function.

Ramos-Alvarez I, Jensen R Biology (Basel). 2025; 14(2).

PMID: 40001881 PMC: 11851965. DOI: 10.3390/biology14020113.


MET Activation in Lung Cancer and Response to Targeted Therapies.

Okun S, Lu D, Sew K, Subramaniam A, Lockwood W Cancers (Basel). 2025; 17(2).

PMID: 39858062 PMC: 11764361. DOI: 10.3390/cancers17020281.


The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance.

Wahoski C, Singh B Cancers (Basel). 2024; 16(13).

PMID: 39001533 PMC: 11240352. DOI: 10.3390/cancers16132472.


C-X-C motif chemokine ligand 12-C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules.

Yen J, Chang C, Hsu H, Yang C, Mani H, Liou J Tzu Chi Med J. 2024; 36(3):231-239.

PMID: 38993827 PMC: 11236080. DOI: 10.4103/tcmj.tcmj_52_24.


Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma.

Zeng M, Liu C, Gong H, Tang Z, Wen J, Wang S Front Mol Biosci. 2024; 11:1367331.

PMID: 38596618 PMC: 11002252. DOI: 10.3389/fmolb.2024.1367331.


References
1.
SANDERS L, Matsumura F, Bokoch G, de Lanerolle P . Inhibition of myosin light chain kinase by p21-activated kinase. Science. 1999; 283(5410):2083-5. DOI: 10.1126/science.283.5410.2083. View

2.
Burridge K . Crosstalk between Rac and Rho. Science. 1999; 283(5410):2028-9. DOI: 10.1126/science.283.5410.2028. View

3.
Potempa S, Ridley A . Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell. 1998; 9(8):2185-200. PMC: 25472. DOI: 10.1091/mbc.9.8.2185. View

4.
Frost J, Khokhlatchev A, Stippec S, White M, Cobb M . Differential effects of PAK1-activating mutations reveal activity-dependent and -independent effects on cytoskeletal regulation. J Biol Chem. 1998; 273(43):28191-8. DOI: 10.1074/jbc.273.43.28191. View

5.
Birchmeier C, Gherardi E . Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 1998; 8(10):404-10. DOI: 10.1016/s0962-8924(98)01359-2. View